Derek Pain: Animalcare can reign with cats and dogs

No Pain, No Gain

Shares greeted 2013 in fine style. I was pleased to see that some constituents of the no-pain, no-gain portfolio joined in the New Year fun, which reflected the fact that the mighty United States economy did not, after all the posturing, tumble over the so-called fiscal cliff.

In my last column I said that investment experts were generally bullish about prospects. Indeed one eminent commentator suggested that shares could well double in the next ten years. He may be right. But such long-term predictions are, in my view, little more than shots in the dark. Indeed even the ritual of forecasting the stock market display over the next 12 months is often a hazardous and unrewarding exercise.

The stock market, although acute at anticipating events, is not a particularly good barometer of the economic and financial climates. It often swings too far, both up and down. Witness the still unconquered peak hit at the turn of the century when dotcom madness sent realistic souls rushing into shares they would normally avoid like the plague. The ragged retreat from that record level was humiliating and painful.

Still, the 2013 approach has undoubtedly been heroic. Indeed shares, with a few hiccups on the way, have made considerable headway since May and have been in particularly fine form from mid-November. I go along with those who expect the stock market to build on its positive start and enjoy a good year.

However, it is worth pointing out that the US problems have not been solved, merely kicked into the long grass. And the UK, along with many other countries, is still deep in the economic mire. A possible stock-market salvation is likely to be the poor interest rates which have undermined the savings industry. The high street rates look weak and unattractive compared with the yields (and growth prospects) that can still be obtained by investing in some blue-chips.

There are hopes that the junior AIM platform may experience a much better year. Indications that ISAs could include AIM stocks must offer encouragement. AIM has been in the dumps for some time as many investors took the view that with the banking crisis taking its toll its constituents were too speculative, and instead settled for blue-chip investments.

AIM has been around since 1995. It was created, after a couple of unsuccessful attempts, to develop a share platform for small, hopefully up-and-coming companies. I suppose it peaked in 2007 when nearly 1,700 companies enjoyed a listing on the junior market. By the end of last year membership was down to just under 1,100 with takeovers as well as graduations to full listings reducing membership. But significant factors in AIM's decline were companies retiring from the market, claiming that the cost of membership was too demanding, and a string of insolvencies.

Maybe the junior platform is over the worst. Paul Mumford of Cavendish Asset Management says he is "quite positive". But he stresses that such is the nature of the junior market that it is wise not to have too many eggs in one basket.

The portfolio has a large proportion of its membership represented by AIM stocks. One of them, Animalcare, has enjoyed a pleasing start to the year with the shares at 145p. They had been bobbing around the 132p level for some time. Cause of the advance was the group's reintroduction of a painkiller for cats and dogs called Buprecare in ampoule form.

The treatment is an important element of Animalcare's array of drugs. In the summer of 2011, the group's supplier decided to stop manufacturing Buprecare ampoules, leaving a noticeable gap in the veterinary group's coverage. Stockbroker N+1 Singer believes the shares now look good value. Analyst Chris Glasper says after a difficult time the outlook is more positive.

The portfolio is still nursing a loss. It acquired the shares at 171p. I am, of course, disappointed by their performance. But hopes the revived product, plus new lines, will help Animalcare battle what is likely to be a tough selling environment could give the stock some added momentum. Buprecare is unlikely to have an immediate impact but should help lift profits.

Independent Partners; Do you need financial advice on your investments, pension or insurance? Book a free consultation with an independent Financial Adviser at VouchedFor.co.uk

PROMOTED VIDEO
Finacial products from our partners
Property search
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

ES Rentals

    iJobs Job Widget
    iJobs Money & Business

    Recruitment Genius: Software Development Manager

    £40000 - £50000 per annum: Recruitment Genius: This is an exciting opportunity...

    Ashdown Group: Product Manager - (Product Marketing, Financial Services)

    £30000 - £35000 per annum + Benefits: Ashdown Group: Marketing Manager - Marke...

    Recruitment Genius: Compliance Assistant

    £13000 per annum: Recruitment Genius: This Pension Specialist was established ...

    Ashdown Group: Market Research Executive

    £23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...

    Day In a Page

    Isis hostage crisis: The prisoner swap has only one purpose for the militants - recognition its Islamic State exists and that foreign nations acknowledge its power

    Isis hostage crisis

    The prisoner swap has only one purpose for the militants - recognition its Islamic State exists and that foreign nations acknowledge its power, says Robert Fisk
    Missing salvage expert who found $50m of sunken treasure before disappearing, tracked down at last

    The runaway buccaneers and the ship full of gold

    Salvage expert Tommy Thompson found sunken treasure worth millions. Then he vanished... until now
    Homeless Veterans appeal: ‘If you’re hard on the world you are hard on yourself’

    Homeless Veterans appeal: ‘If you’re hard on the world you are hard on yourself’

    Maverick artist Grayson Perry backs our campaign
    Assisted Dying Bill: I want to be able to decide about my own death - I want to have control of my life

    Assisted Dying Bill: 'I want control of my life'

    This week the Assisted Dying Bill is debated in the Lords. Virginia Ironside, who has already made plans for her own self-deliverance, argues that it's time we allowed people a humane, compassionate death
    Move over, kale - cabbage is the new rising star

    Cabbage is king again

    Sophie Morris banishes thoughts of soggy school dinners and turns over a new leaf
    11 best winter skin treats

    Give your moisturiser a helping hand: 11 best winter skin treats

    Get an extra boost of nourishment from one of these hard-working products
    Paul Scholes column: The more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him

    Paul Scholes column

    The more Jose Mourinho attempts to influence match officials, the more they are likely to ignore him
    Frank Warren column: No cigar, but pots of money: here come the Cubans

    Frank Warren's Ringside

    No cigar, but pots of money: here come the Cubans
    Isis hostage crisis: Militant group stands strong as its numerous enemies fail to find a common plan to defeat it

    Isis stands strong as its numerous enemies fail to find a common plan to defeat it

    The jihadis are being squeezed militarily and economically, but there is no sign of an implosion, says Patrick Cockburn
    Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action

    Virtual reality: Seeing is believing

    Virtual reality thrusts viewers into the frontline of global events - and puts film-goers at the heart of the action
    Homeless Veterans appeal: MP says Coalition ‘not doing enough’

    Homeless Veterans appeal

    MP says Coalition ‘not doing enough’ to help
    Larry David, Steve Coogan and other comedians share stories of depression in new documentary

    Comedians share stories of depression

    The director of the new documentary, Kevin Pollak, tells Jessica Barrett how he got them to talk
    Has The Archers lost the plot with it's spicy storylines?

    Has The Archers lost the plot?

    A growing number of listeners are voicing their discontent over the rural soap's spicy storylines; so loudly that even the BBC's director-general seems worried, says Simon Kelner
    English Heritage adds 14 post-war office buildings to its protected lists

    14 office buildings added to protected lists

    Christopher Beanland explores the underrated appeal of these palaces of pen-pushing
    Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

    Human skull discovery in Israel proves humans lived side-by-side with Neanderthals

    Scientists unearthed the cranial fragments from Manot Cave in West Galilee